Soleil Securities Initiates Coverage on Pfizer (PFE) with a Buy
Tweet Send to a FriendGet Alerts PFE Hot Sheet
Price: $29.04 -0.24%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade PFE Now!
Soleil Securities initiates coverage on Pfizer (NYSE: PFE) with a Buy. Price target $20. Risk/Reward Compelling as Bad News Priced In
Soleil analyst says, "Largest U.S. pharma with cholesterol-lowering Lipitor its cash cow...We believe the generic competition for Lipitor in November 2011 is well understood and priced into the stock at the current valuation. In our opinion, the Company's 1) acquisition capabilities, 2) late-stage pipeline (24 compounds in Phase III), and 3) 8.0% dividend yield are being discounted. We see the stock moving higher as a significant M&A target is identified, the late-stage pipeline shows advances, further operational streamlining initiatives are taken, and a seemingly directionless management team is either replaced or prodded into action."
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals.
Soleil analyst says, "Largest U.S. pharma with cholesterol-lowering Lipitor its cash cow...We believe the generic competition for Lipitor in November 2011 is well understood and priced into the stock at the current valuation. In our opinion, the Company's 1) acquisition capabilities, 2) late-stage pipeline (24 compounds in Phase III), and 3) 8.0% dividend yield are being discounted. We see the stock moving higher as a significant M&A target is identified, the late-stage pipeline shows advances, further operational streamlining initiatives are taken, and a seemingly directionless management team is either replaced or prodded into action."
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals.
You May Also Be Interested In
- Pfizer (PFE) to Split Off Remaining Interest in Zoetis (ZTS)
- Notable Mergers and Acquisitions of the Day 05/22: (PFE)/(ZTS) (MBND) (CLWR)/(S) (GAGA)
- Topeka Capital Starts Spansion (CODE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Soleil Securities, Dividend
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
